In addition to investing in innovative science and technology ventures, Beyond Next Ventures runs one of the largest technology-specific acceleration programs in Japan, Blockbuster TOKYO, which accelerates the growth of drug discovery and medical ventures Blockbuster TOKYO provides various types of support to accelerate the growth of drug discovery and medical ventures.
The training program consists of two programs: a training program and a selection program. In the training program, seminars are held about once a month to provide participants with the knowledge necessary for venture management, fundraising, R&D, business alliances, and other venture-related knowledge. In the selection program, teams with more specific business plans are provided with specialized support by mentors who are familiar with each field, such as drug discovery, intellectual property, and marketing, as well as practical support such as matching them with the necessary human resources. Nineteen teams have been selected to participate in the selection program.
Selected Program Participating Teams

Beyond Next VenturesWhat is
Beyond Next Ventures, founded in August 2014, is an independent accelerator specializing in incubation investment in technology startups. The company has abundant investment experience and an excellent track record in the areas ranging from support for the commercialization of university seeds to investment and growth support, and manages the largest fund in the country for an accelerator, with a cumulative total of just under 15 billion yen from the first fund established in February 2015 and the second fund established in October 2018.
In addition to funding, we are also actively involved in commercialization support through the "BRAVE Acceleration Program" (URL: ). http://brave.team/(URL: ) provides researchers/entrepreneurs seeking to commercialize innovative technologies with the knowledge, network, and growth capital needed to match them with potential management personnel and to realize commercialization. In addition, the Tokyo Metropolitan Government has commissioned Blockbuster TOKYO, a program to support the startup and growth of drug discovery and medical ventures (URL: https://www.blockbuster.tokyo/In February 2019, the company will open Beyond BioLAB TOKYO (URL: ), a shared wet lab in Chuo-ku, Tokyo, as a base for providing commercialization support, including R&D, to startups in the life science field. http://biolab.beyondnextventures.com/ From March 2019, the company will launch Co-founders (URL: ), a co-founder matching platform specializing in technology seeds and researchers at universities and other institutions. https://co-founders.team/) to help build strong start-up teams through online and real-life matching support.
| Company Name | Beyond Next Ventures, Inc. |
| Date of Establishment | August 2014 |
| address (e.g. of house) | 1 Nihonbashi Murohon Building 1-4-3 Nihonbashi-Honcho, Chuo-ku, Tokyo |
| representative director (i.e. someone chosen by the board of directors from among the directors to actually represent the company)president (e.g. of a company) | Tsuyoshi Ito |
| Company HP | http://beyondnextventures.com |
Distributed by: PR TIMES






